01—Abstract
Summary
Summary of the 8-K filed February 10, 2026. Cited figures are marked; the original filing is the authoritative source.
Astera Labs, Inc. (ALAB) announced on February 10, 2026, that it entered into a Transaction Agreement and a Warrant Agreement with Amazon.com, Inc. (Parent) and Amazon.com NV Investment Holdings LLC (Warrantholder), respectively, on February 5, 2026.
This agreement allows for the issuance of a warrant to acquire up to approximately 3.26 million shares of common stock at an exercise price of $142.82a per share. The warrant is tied to performance conditions, specifically requiring Parent and its affiliates to purchase up to $6.5 billion of Astera Labs' smart fabric switch products, signal conditioning products, and optical engine products.
02—Key points
Key Highlights
- Astera Labs entered into a significant strategic agreement with Amazon.com.
- A warrant allows Amazon.com to acquire up to 3,262,299 shares of Astera Labs' common stock.
- The warrant exercise price is set at $142.82 per share.
- The warrant is performance-based, contingent upon Amazon.com purchasing up to $6.5 billion in Astera Labs products.
- The warrant has an exercise period extending through February 5, 2033.
- The issuance of the warrant and associated shares is being conducted under an exemption from registration, citing Section 4(a)(2) of the Securities Act.
- The agreement includes customary anti-dilution adjustments for the warrant and its shares.
03—Questions
Frequently Asked Questions
What is the primary purpose of the agreement with Amazon?
The primary purpose is to incentivize and secure significant future sales of Astera Labs' core products (smart fabric switches, signal conditioning, and optical engines) from Amazon.com, a major customer. The warrant's exercise is directly linked to the volume of these product purchases.
How does this warrant impact Astera Labs' share count?
If fully exercised, the warrant could result in the issuance of up to 3,262,299 new shares of common stock. This would increase the total number of outstanding shares, potentially leading to dilution for existing shareholders.
Is this a new warrant or an amendment to an existing one?
The filing mentions the Parent holds a warrant issued in October 2022, as amended in October 2023. This new agreement seems to be a separate and more substantial warrant agreement, linked to future product purchases, rather than a simple amendment to the prior one.
What are the implications of the warrant being issued without registration under the Securities Act?
The company is relying on an exemption (Section 4(a)(2)) for this private placement. This means the shares issued upon exercise of the warrant will likely be restricted and will bear customary legends. Investors should be aware that these shares may not be freely tradable in the public market without further registration or exemption.
04—Continue